These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 6047211)

  • 1. [Absorption and enzymatic inactivation of phosphorylated insulin following oral administration].
    Roubal Z; Zikmund E; Franc Z; Pádr Z
    Vnitr Lek; 1967 Apr; 13(4):369-81. PubMed ID: 6047211
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin.
    Ji Y; Liu C; Pei YY
    Acta Pharmacol Sin; 2007 May; 28(5):744-50. PubMed ID: 17439732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
    Wang J; Tabata Y; Morimoto K
    J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles.
    Mesiha MS; Sidhom MB; Fasipe B
    Int J Pharm; 2005 Jan; 288(2):289-93. PubMed ID: 15620869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of proteolytic enzymes and their inhibitors on absorption from the abdominal cavity].
    Synovets AS; Levitskii AP; Sinovets AA; Zubkov OB
    Fiziol Zh (1978); 1980; 26(5):692-5. PubMed ID: 7000553
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
    Chae SY; Jin CH; Shin HJ; Youn YS; Lee S; Lee KC
    Bioconjug Chem; 2008 Jan; 19(1):334-41. PubMed ID: 18078308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
    Wu ZH; Ping QN; Lei XM; Li JY; Cai P
    Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral delivery system of insulin microspheres: effect on relative hypoglycemia of diabetic albino rats.
    Senthil Rajan D; Mandal UK; Veeran Gowda K; Bose A; Ganesan M; Pal TK
    Boll Chim Farm; 2004 Oct; 143(8):315-8. PubMed ID: 15884295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sperminated polymers on the pulmonary absorption of insulin.
    Seki T; Fukushi N; Chono S; Morimoto K
    J Control Release; 2008 Feb; 125(3):246-51. PubMed ID: 18031861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
    Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
    Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
    J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of lectin-modified insulin liposomes as carriers for oral administration.
    Zhang N; Ping QN; Huang GH; Xu WF
    Int J Pharm; 2005 Apr; 294(1-2):247-59. PubMed ID: 15814248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency.
    Liang JF; Yang VC
    Biochem Biophys Res Commun; 2005 Sep; 335(3):734-8. PubMed ID: 16115469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical study of insulin suppositories.
    Mesiha MS; Lobel S; Salo DP; Khaleeva LD; Zekova NY
    Pharmazie; 1981; 36(1):29-32. PubMed ID: 7012849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lanthanides enhance pulmonary absorption of insulin.
    Shen ZC; Cheng Y; Zhang Q; Wei SL; Li RC; Wang K
    Biol Trace Elem Res; 2000; 75(1-3):215-25. PubMed ID: 11051611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intestinal passage of insulin and proteolytic enzymes].
    Nakano A; Sato N; Ohara A; Muramatsu N
    Horumon To Rinsho; 1967 May; 15(5):411-7. PubMed ID: 6070988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
    Qi R; Ping QN; Zhao W
    Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.
    Fetih G; Habib F; Okada N; Fujita T; Attia M; Yamamoto A
    J Control Release; 2005 Sep; 106(3):287-97. PubMed ID: 15982776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.